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SUMMARY 
A series of tri- and tetrapeptides sharing the amino-terminal dipeptide unit Tyr-Tic, found in the high-affinity 
delta opioid receptor antagonist Tyr-Tic-Phe-Phe (TIPP), was prepared and evaluated in receptor binding assays 
to explore the role(s) of the phenylalanine residues in positions 3 and 4. It was found that aromaticity of residues 
3 and 4 is not required for high affinity, a lipophilic side chain in either location being sufficient, as evidenced by 
the high delta receptor binding affinities observed for the tetrapeptide Tyr-Tic-Ala-Leu and the tripeptide Tyr-Tic- 
Leu. These results support the suggestion of Temussi et al. [Biochem. Biophys. Res. Commun., 198 (1994) 933] that 
the aromatic side chain of the Tic residue corresponds to the aromatic side chain found in residues 3 or 4 in other 
delta-selective peptide series. 
INTRODUCTION 
Recently, Schiller and co-workers have de- 
scribed a novel series of opioid peptides based up- 
on the lead tetrapeptide Tyr-Tic-Phe-Phe (TIPP), 
where Tic is tetrahydroisoquinoline carboxylic 
acid [1-3]. This lead compound, analogs maintain- 
ing the amino-terminal tripeptide sequence, and 
the tripeptide itself display high affinity for the 
delta type of opioid receptor. They are the most 
selective ligands yet reported for this receptor and 
are potent antagonists in delta receptor-mediated 
bioassays. Unlike other opioid peptides, in the 
TIPP series high affinity for delta receptors re- 
quires L-stereochemistry of the second residue, the 
conformationally constrained phenylalanine ana- 
log Tic. It is widely accepted that the phenyl- 
alanine (or related aromatic) side chain occurring 
in residue 3 (dermorphins and deltorphins and 
their analogs) or residue 4 (enkephalins and ana- 
logs) is a key pharma-cophore element for opioid 
receptor recognition and, based upon the high 
affinity exhibited by the Tyr-Tic-Phe moiety, 
Schiller and co-workers have also proposed that 
the Tyr-Tic-Phe tripeptide of the TIPP peptides 
constitutes the delta opioid receptor message [1]. 
In a recent report, Temussi et al. [4] cast doubt 
on this premise by demonstrating that the dipep- 
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tides Tyr-Tic-OH and Tyr-Tic-NH2 are themselves 
delta-selective antagonists. The authors propose 
that the aromatic ring of the Tic residue serves 
the function of the second aromatic group of the 
opioid message (in addition to Tyr l) and report 
that low-energy conformers of Tyr-Tic-NH2 can 
be superimposed with the rigid alkaloid nal- 
trindole (NTI), a potent delta-selective antagonist 
developed by Portoghese and colleagues [5]. 
Although the conclusions of Temussi et al. are 
not unreasonable, the relatively low binding 
affinity and weak antagonist potency of the Tyr- 
Tic dipeptides (2-3 orders of magnitude lower 
than reported values for TIPP [1] and NTI [5]) 
causes some concern. Since this affinity reduction 
corresponds to ~3-4 kcal/mole of binding energy, 
an additional specific interaction between the 
aromatic side chain of the Phe 3 residue of TIPP 
and the delta opioid receptor might be necessary 
to realize a high-affinity interaction. We report 
here that, in fact, aromaticity is not required for 
residue 3 in TIPP, a lipophilic residue in either 
this position or in position 4 being sufficient to 
provide high delta receptor binding affinity. Our 
results suggest, in agreement with the proposal of 
Temussi et al., that it is the aromatic Tic side 
chain in TIPP and its analogs which corresponds 
to the phenylalanine residue found in other 
classes of opioid peptides and that the Phe 3 
residue of TIPP provides additional binding 
energy via its lipophilic character. 
METHODS 
Peptides 1, 3, and 4 of Table 1 were synthe- 
sized by previously described [6] standard solid- 
phase procedures using chloromethylated poly- 
styrene (Merrifield) resin, cross-linked with 1% 
divinylbenzene. Trifluoroacetic acid (TFA) was 
employed for deprotection, and dicyclo-hexylcar- 
bodiimide (DCC) and 1-hydroxybenzo-triazole 
(HOBt) were used as coupling agents. The t- 
butyloxycarbonyl (Boc) group was used for the 
protection of o~-amino functions. Deprotection 
and cleavage from the resin were accomplished by 
treatment with anhydrous hydrogen fuoride in 
the presence of 5% cresol and 5% p-thiocresol, 
with stirring for 45 min at 0 °C. HF was sub- 
sequently removed by vacuum. Following extract- 
ion with 9:1 DMF:80% HOAc and dilution with 
0.1% TFA in water, the resulting peptides were 
purified by reversed phase high performance 
liquid chromatography (RP-HPLC) on a Vydac 
218TP C-18 column (2.5 x 22 cm) using the sol- 
vent system 0.1% (w/v) TFA in water/0.1% (w/v) 
TFA in acetonitrile, by a gradient of 10-50% 
organic component in 40 rain at a flow rate of 10 
ml/min, and were subsequently lyophilized. The 
remaining peptides were synthesized employing 9- 
fluorenylmethyloxycarbonyl (Fmoc) protection of 
the amino functions, with deprotection by piper- 
idine and coupling mediated by 2-(1H-benzotria- 
zol- 1-yl)- 1,1,3,3-tetramethyluronium hexafluoro- 
phosphate (HBTU). These syntheses utilized hy- 
droxymethylphenoxymethyl (HMP) resins from 
which the peptides were cleaved using a 95% 
solution of TFA in CH2CI z The resulting peptides 
were purified by RP-HPLC as described above. 
Final peptide purity was determined by ana- 
lytical RP-HPLC on a Vydac 218TP C-18 column 
(4.6 x 250 mm) by a gradient of 0-70% organic 
component over 70 min, with a flow rate of  1 
ml/min. All analytical RP-HPLC gradients were 
run using the solvent system 0.1% (w/v) TFA in 
water/0.1% (w/v) TFA in acetonitrile. Peaks were 
monitored at 220, 230, 254 and 280 nm and ana- 
lyzed with Waters Maxima 820 software. Peaks 
which also appeared in chromatograms in which 
no peptide was injected were considered to be 
artifacts and were ignored. Peptide purity was 
then evaluated by integration of peaks and was 
found to be >97% for each of the peptides 
reported here. Retention times (min) of the pep- 
tides under the conditions described above were: 
1: 40.3; 2: 34.6; 3: 32.8; 4: 35.8; 5: 32.5; 6: 23.0; 
and 7: 36.4. Final product confirmation was ob- 
tained by fast atom bombardment-mass spectro- 
metry (FAB-MS). In all cases, the anticipated 
molecular weights were confirmed by FAB-MS. 
Opioid receptor binding assays of test ligands 
TABLE 1 
BINDING AFFINITIES AND SELECTIVITIES OF TYR-TIC PEPTIDES 
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Peptide K i (nM) 
[3H]-DAMGO [3H]-DPDPE 
K~ (~t)/K~ 05) 
1 Tyr-Tic-Phe-Phe-OH > 10 000 
2 Tyr-Tic-Phe-OH > 10 000 
3 Tyr-Tic-Phe-Ala-OH >10 000 
4 Tyr-Tic-Ala-Phe-OH > 10 000 
5 Tyr-Tic-Ala-Leu-OH > 10 000 
6 Tyr-Tic-Ala-OH > 10 000 
7 Tyr-Tic-Leu-OH > 10 000 
2.75 + 0.22 >3640 
8.90 _+ 1.34 >1120 
17.7 _+ 1.95 >565 
3.20 + 0.28 >3130 
7.11 + 0.77 >1400 
236 _+ 41 >42 
4.33 + 0.75 >2300 
were performed on membrane preparations from 
guinea pig brain, as previously described [7]. 
Binding affinities were measured at 0 °C in com- 
petition binding assays using [3H]-DPDPE or [3H]- 
DAMGO as radioligands selective for delta or mu 
opioid receptors, respectively, and are reported as 
inhibition constants Ki. Each reported K~ value 
and standard error of the mean (sem) is based 
upon at least two independent binding experi- 
ments, each done in triplicate. Binding affinities 
for kappa opioid receptors were also assessed, 
using [3H]-U69,593 as the radioligand. None of 
the analogs displayed significant affinity for this 
receptor (Ki >> 10 000 nM). 
RESULTS AND DISCUSSION 
Table l summarizes the results of opioid 
receptor binding assays on a series of TIPP 
analogs designed to probe the importance of the 
phenylalanine residues in positions 3 and 4 of 
TIPP. As shown in Table 1 and in agreement with 
the results of Schiller and co-workers, TIPP (1) 
and TIP (2) bind with high affinity to the delta 
opioid receptor, as evidenced by their low K~ 
values in competitive binding with the delta- 
selective radioligand [3H]-DPDPE. Both ligands 
display high selectivity for the delta receptor, 
neither compound exhibiting significant affinity 
for the mu receptor (competitive binding with the 
mu-selective [3H]-DAMGO, Table 1) or the kappa 
receptor (data not shown). Based upon the high 
delta affinity of the tripeptide TIP, Schiller and 
co-workers have proposed that the tripeptide 
sequence Tyr-Tic-Phe comprises the opioid recep- 
tor message in the TIPP peptide series [1]. The 
results observed for 3 and 4, in which the phenyl- 
alanine residues of TIPP are individually replaced 
by alanine, however, are inconsistent with this 
view, since the delta affinity observed for 4, in 
which the Phe 3 residue is replaced, is significantly 
higher than that for 3, in which the Phe 4 residue 
is replaced. While this observation casts doubt 
upon the importance of the aromatic nature of 
the Phe 3 residue for delta-receptor recognition by 
TIP and TIPP, the possibility that, owing to the 
expected flexibility of these linear peptides, the 
Phe 4 residue of 4 may be able to assume the role 
of the Phe 3 residue of TIPP cannot be excluded. 
The result observed for 5, however, argues against 
this possibility. This analog, which contains no 
aromatic residue in positions 3 or 4, nonetheless 
shows similar delta-binding affinity as TIPP and 
its Ala 3 analog 4. Apparently it is the lipophilic 
nature of residues 3 and 4 that is necessary for 
high delta affinity, indicating that neither Phe 3 
nor Phe 4 in TIPP correspond to the second 
aromatic side chain (in addition to that of 
tyrosine) important for receptor recognition by 
the enkephalins, der-morphins and deltorphins. 
This is further suggested by the low delta affinity 
observed for the Ala 3 tripeptide 6 compared with 
TIP, which binds 25-fold more avidly. Presumably 
the alanyl side chain provides insufficient lipo- 
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philicity for optimal interaction with the receptor. 
By contrast, the more lipophilic leucine side chain 
in 7 pro-vides additional interaction energy and 
results in similar binding affinity as that observed 
for TIE 
If, as is clear from the above, aromatic side 
chains are not required at residues 3 or 4 in the 
TIPP series of delta-selective peptides, then it 
follows that either the aromatic side chain of the 
Tic  2 residue is important for receptor binding and 
corresponds to the phenylalanine side chain found 
in residue 3 or 4 in endogenous opioids and 
related analogs, or the TIPP peptides bind to the 
delta receptor in a distinctly different fashion. 
While the latter possibility cannot be unequi- 
vocally ruled out, the conformational comparison 
of Tyr-Tic-NH2 and naltrindole described by 
Temussi et al. and theoretical conformational 
analyses carried out in our laboratory, which 
indicate that low-energy conformations of TIPP 
can be readily fit to a pharmacophore model for 
the delta opioid receptor (Lomize, A., Pogozheva, 
I. and Mosberg, H.I., manuscript in preparation), 
argue for the former. The importance of the 
aromatic side chain of Tic for delta receptor 
recognition was deduced by Schiller and co- 
workers from the observation that replacement of 
L-Tic by L-pipecolic acid, which retains the 
piperidine ring of Tic but not the fused aromatic 
ring, leads to a drastic loss of delta-binding 
affinity, accompanied by a great increase in mu- 
binding affinity [8]. The results reported here 
support the conclusion of Temussi et al. that this 
importance is founded upon the correspondance 
of the aromatic ring of the L-Tic 2 side chain with 
the aromatic side chain found in residues 3 or 4 
in other delta-selective peptide series. The results 
also clearly demonstrate that, compared with the 
Tyr-Tic dipeptide, the additional binding energy 
of TIPP and related tri- and tetrapeptides derives 
from the lipophilic nature of the residues at 
position 3 or 4, not their aromatic character. 
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